Literature DB >> 10713183

p21-activated kinase 1 plays a critical role in cellular activation by Nef.

O T Fackler1, X Lu, J A Frost, M Geyer, B Jiang, W Luo, A Abo, A S Alberts, B M Peterlin.   

Abstract

The activation of Nef-associated kinase (NAK) by Nef from human and simian immunodeficiency viruses is critical for efficient viral replication and pathogenesis. This induction occurs via the guanine nucleotide exchange factor Vav and the small GTPases Rac1 and Cdc42. In this study, we identified NAK as p21-activated kinase 1 (PAK1). PAK1 bound to Nef in vitro and in vivo. Moreover, the induction of cytoskeletal rearrangements such as the formation of trichopodia, the activation of Jun N-terminal kinase, and the increase of viral production were blocked by an inhibitory peptide that targets the kinase activity of PAK1 (PAK1 83-149). These results identify NAK as PAK1 and emphasize the central role its kinase activity plays in cytoskeletal rearrangements and cellular signaling by Nef.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713183      PMCID: PMC85477          DOI: 10.1128/MCB.20.7.2619-2627.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Emerging from the Pak: the p21-activated protein kinase family.

Authors:  M A Sells; J Chernoff
Journal:  Trends Cell Biol       Date:  1997-04       Impact factor: 20.808

Review 2.  Functions of lipid rafts in biological membranes.

Authors:  D A Brown; E London
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

3.  HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis.

Authors:  M Wiskerchen; C Cheng-Mayer
Journal:  Virology       Date:  1996-10-01       Impact factor: 3.616

4.  Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules.

Authors:  S Le Gall; L Erdtmann; S Benichou; C Berlioz-Torrent; L Liu; R Benarous; J M Heard; O Schwartz
Journal:  Immunity       Date:  1998-04       Impact factor: 31.745

5.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

6.  Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization.

Authors:  O T Fackler; N Kienzle; E Kremmer; A Boese; B Schramm; T Klimkait; C Kücherer; N Mueller-Lantzsch
Journal:  Eur J Biochem       Date:  1997-08-01

7.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.

Authors:  P Crespo; K E Schuebel; A A Ostrom; J S Gutkind; X R Bustelo
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

8.  RAC regulation of actin polymerization and proliferation by a pathway distinct from Jun kinase.

Authors:  T Joneson; M McDonough; D Bar-Sagi; L Van Aelst
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

9.  PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.

Authors:  A Abo; J Qu; M S Cammarano; C Dan; A Fritsch; V Baud; B Belisle; A Minden
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

10.  Differential effects of PAK1-activating mutations reveal activity-dependent and -independent effects on cytoskeletal regulation.

Authors:  J A Frost; A Khokhlatchev; S Stippec; M A White; M H Cobb
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

View more
  43 in total

Review 1.  Structure--function relationships in HIV-1 Nef.

Authors:  M Geyer; O T Fackler; B M Peterlin
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

2.  Subunit H of the V-ATPase involved in endocytosis shows homology to beta-adaptins.

Authors:  Matthias Geyer; Oliver T Fackler; B Matija Peterlin
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

3.  Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix.

Authors:  Tatyana Dorfman; Elena Popova; Massimo Pizzato; Heinrich G Göttlinger
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 4.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

5.  Involvement of the Rac1-IRSp53-Wave2-Arp2/3 Signaling Pathway in HIV-1 Gag Particle Release in CD4 T Cells.

Authors:  Audrey Thomas; Charlotte Mariani-Floderer; Maria Rosa López-Huertas; Nathalie Gros; Elise Hamard-Péron; Cyril Favard; Theophile Ohlmann; José Alcamí; Delphine Muriaux
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

6.  Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective.

Authors:  Sharilyn Almodovar; Stefania Cicalini; Nicola Petrosillo; Sonia C Flores
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

7.  Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity.

Authors:  O T Fackler; P d'Aloja; A S Baur; M Federico; B M Peterlin
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX.

Authors:  G H Renkema; A Manninen; K Saksela
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.

Authors:  J L Foster; R P Molina; T Luo; V K Arora; Y Huang; D D Ho; J V Garcia
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Alkylating HIV-1 Nef - a potential way of HIV intervention.

Authors:  Yong-Jiu Jin; Xiaoping Zhang; Catherine Yi Cai; Steven J Burakoff
Journal:  AIDS Res Ther       Date:  2010-07-26       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.